Dendreon and Medivation initiated at Wedbush (36.41)
Wedbush says prostate cancer is the most commonly diagnosed cancer in men. Depending on the state of the disease being local or metastatic, hormone sensitive or castration resistant, asymptomatic or symptomatic, a variety of agents are in use or being developed for the various stages of the disease. Firm says Dendreon (DNDN) and Medivation (MDVN) bring important advancement and options to the treatment of prostate cancer. Dendreon's Provenge is the first immunotherapy ever approved, and the company's goal is to establish it as the standard front line therapy for metastatic castration-resistant prostate cancer. They believe Medivation's MDV3100, together with JNJ's abiraterone, both in Phase III development, are among the most promising agents possessing broad utilities not only in the mCRPC setting, but also the possibility of moving earlier in the disease continuum to the hormone sensitive stage. Firm initiates Dendreon (DNDN) with a Neutral and a $39 tgt and assumes coverage of Medivation (MDVN) with an Outperform and $25 tgt.
Darkman. i followed you over here, before you drive ogxi down the tube as you did isis, have a heart. Stay on the isis board ! I am a vical fan of yours, listen to me!
At first I thought this post was "pithy" so I looked it up...nope, that's not it.
Then I thought it might be "witty" so I looked that up...nope, not it either.
Then it occurred to me that it might be an entirely different commentative genre; perhaps "disengenuous"...nah, that ain't it.
Then I looked up "juvenile."
Checking in real quick I see more insider selling. OUCH. Scotty Slick boy Cormack continues his buying and selling the same day Dec. 1st-10 @ $3.89 and out @ $16.02. I like being polite too so I wish you OGXI suckers well. Whoops, I mean you nice people holding on to this latest antisense scam, whoops, I take that back. Wait a minute, why can't I tell the truth? Ok, keep on nailing them dark Scottie boy. Peace and love. :>)
Thanks mr.ssssamsa and summer, your thoughts are appreciated. Hopefully I'll get re-engaged after Xmas.
We have a great board here because we contribute, try to be polite, and learn from one another's different points of view.
Dr. K, I just wanted to second Howard's sentiments. I think most of us who follow this board feel as though we know you, because you're the one who sets the tone of civility and good humor that distinguishes the board from most others on Yahoo. I'm relieved things turned out as they did for your wife.
As far as the CC went, it had a Q&A format that made it more interesting than most. The only news I caught was that even though OGXI now has the money to fund the randomized bladder trial for 427 as well as the randomized prostate trial, it's still evaluating whether to partner in order to advance other indications for 427 as well as the other pipeline compounds.